| Date Filed | Type | Description |
| 06/09/2023 |
4
| Ho Maykin (Director) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 8,289 shares
@ $0
Sold 2,295 shares
@ $16.79, valued at
$38.5k
Sold 6,225 shares
@ $17.68, valued at
$110.1k
Granted 12,666 options to buy
@ $17.13, valued at
$217k
|
|
| 06/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/24/2023 |
4
| Ho Maykin (Director) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 4,190 shares
@ $0 |
|
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/08/2020 |
4
| Ho Maykin (Director) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 4,700 shares
@ $0
Granted 7,800 options to buy
@ $32.69, valued at
$255k
|
|
| 06/01/2020 |
4
| Ho Maykin (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Granted 8,096 options to buy
@ $53.35, valued at
$431.9k
Granted 1,686 restricted stock units
@ $0
Exercised 1,878 restricted stock units
@ $0 |
|
| 06/07/2019 |
4
| Ho Maykin (Director) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 4,700 shares
@ $0
Granted 7,800 options to buy
@ $39.03, valued at
$304.4k
|
|
| 05/31/2019 |
4
| Ho Maykin (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Granted 8,919 options to buy
@ $47.91, valued at
$427.3k
Granted 1,878 restricted stock units
@ $0
Exercised 1,400 restricted stock units
@ $0 |
|
| 02/07/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 12/07/2018 |
4
| Ho Maykin (Director) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 1,855 shares
@ $0
Granted 10,400 options to buy
@ $41.34, valued at
$429.9k
Granted 3,008 options to buy
@ $41.34, valued at
$124.4k
|
|
| 12/07/2018 |
3
| Ho Maykin (Director) has filed a Form 3 on FIBROGEN INC |
| 06/04/2018 |
4
| Ho Maykin (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Granted 5,700 options to buy
@ $93.5, valued at
$533k
Granted 1,400 restricted stock units
@ $0 |
|
| 10/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/16/2016 |
4
| Ho Maykin (Director) has filed a Form 4 on PAREXEL INTERNATIONAL CORP|
Txns:
| Granted 2,369 shares
@ $0 |
|
| 06/23/2016 |
4
| Ho Maykin (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS INC|
Txns:
| Granted 8,000 options to buy
@ $47.33, valued at
$378.6k
|
|